Compare Agilent Technologies Inc (A) vs ON Holding AG (ONON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs ON Holding AG — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while ON Holding AG trades at $31.21 (market cap $12.93B). The key difference: Agilent Technologies Inc is far larger — about 3.2× ON Holding AG's market cap, and Agilent Technologies Inc pays a 0.69% dividend while ON Holding AG pays none. Which is the better fit depends on your goals.
| A | ONON | |
|---|---|---|
Market Cap | $42.00B | $12.93B |
Sector | Health | Technology |
52-Week High | $157.20 | $50.63 |
52-Week Low | $110.24 | $31.88 |
Enterprise Value | $43.55B | $12.25B |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
ONON trades at $37.55, up 0.56% with bullish technical signals supported by moving averages. The company demonstrates strong fundamental performance with Q1 2026 EPS beating expectations at $0.47 vs. $0.34 expected, maintaining a streak of earnings surprises. Revenue growth to $3.01B in 2025 and expanding net margins to 8.02% reflect operational strength amid positive analyst sentiment.
The outlook remains positive with 77% analyst buy ratings and $52.57 consensus price target suggesting 40% upside potential. Key risks include premium valuation metrics (P/E 41.8, P/S 6.5) and tariff exposure, but strong DTC growth and margin expansion support the bullish case for growth investors seeking athletic footwear exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About ON Holding AG
ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →
